JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Preoperative scoring system for predicting microvascular invasion in intrahepatic cholangiocarcinoma using gadoxetate-enhanced MRI

  • 0Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
European Radiology +

|

June 6, 2025

|

June 6, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

A new risk scoring system using gadoxetate-enhanced MRI can predict microvascular invasion (MVI) in intrahepatic cholangiocarcinoma (ICCA). This tool identifies patients with poorer survival outcomes, aiding personalized treatment strategies.

Area Of Science

  • Hepatobiliary imaging
  • Oncologic imaging
  • Radiology

Background

  • Microvascular invasion (MVI) is a critical prognostic factor in intrahepatic cholangiocarcinoma (ICCA).
  • Preoperative prediction of MVI using gadoxetate-enhanced MRI has not been well-established.
  • Accurate MVI assessment is crucial for surgical planning and patient management.

Purpose Of The Study

  • To develop and validate a preoperative risk scoring system for predicting MVI in ICCA.
  • To integrate clinical and gadoxetate-enhanced MRI features into the scoring system.
  • To assess the correlation between MVI risk and patient survival outcomes.

Main Methods

  • Retrospective analysis of 197 ICCA patients who underwent preoperative gadoxetate-enhanced MRI and curative resection.
  • Random division of patients into development (n=139) and validation (n=58) cohorts.
  • Development of a risk scoring system using multivariable logistic regression based on MRI features (tumor multiplicity, arterial-phase peritumoral enhancement, hepatobiliary-phase peritumoral hypointensity).

Main Results

  • The developed risk scoring system demonstrated strong diagnostic performance (AUC 0.80 in development, 0.84 in validation).
  • Key MRI predictors for MVI included tumor multiplicity, arterial-phase peritumoral enhancement, and hepatobiliary-phase peritumoral hypointensity.
  • High MVI risk was significantly associated with shorter recurrence-free survival (RFS) and overall survival (OS) in both cohorts.

Conclusions

  • The novel risk scoring system effectively predicts MVI in ICCA using gadoxetate-enhanced MRI.
  • This tool facilitates preoperative identification of ICCA patients at high risk for MVI and poorer prognosis.
  • The scoring system offers valuable prognostic insights to guide personalized treatment strategies and improve patient outcomes.

Keywords: